HOW IT WORKS
Created by Nature, Enhanced by Science
Our Patents
Innovation protected by intellectual property
US5429823A
US6602861B1
US66354A
CZ280686B6
CZ282139B6
DK1406641T3
EP1426053A1
CN1852721B
PL1871399T3
WO2012088414A1
PL217384B1
WO2015104284A1
PHOSPHOLIPID COMPOSITIONS
CN201780041147.7A
KR1020197002656A
SG11201811776WA
MX2018016091A
CA3029419A
AU2017290724A
BR112018077350-6A
JP2018569135A
RU2019102212A
EP17821214.8A
IL263838A
PH12019500026A
Heading
Exclusive Licensing Agreement
We have an exclusive licensing agreement with Machavert Pharmaceuticals on their patent portfolio "Phospholipid Compositions."
Patent Portfolio
Primary Patent: Phospholipid Compositions (WO2018005735A1)
This patent family includes multiple international filings covering innovative phospholipid compositions with therapeutic applications.
Scientific Publications & Presentations
Conference Presentations:
- Edinburgh, UK Conference - Poster presentation (featured on our science page)
- AACR (American Association for Cancer Research) - MP1115 presentation by Machavert Pharmaceuticals scientists